 |
ACC 23 Interventional Late-breaking Highlights with Dr Mirvat Alasnag u0026 Dr Khaled Al-Shaibi (Radcliffe Cardiology)
View
|
 |
ESC 2022: 3 Trials That Will Change Your Practice With Interventionalist, Dr Mirvat Alasnag (Radcliffe Cardiology)
View
|
 |
ACC 23 Late-Breaker Discussion: The BIOVASC Trial (Radcliffe Cardiology)
View
|
 |
Day 1 | China Perspectives: ACC.23/WCC Late-Breaking Science Highlights (American College of Cardiology)
View
|
 |
Contemporary diagnosis u0026 management of severe tricuspid regurgitation Firas Zahr u0026 Mirvat Alasnag (CCI Journal)
View
|
 |
ACC 23: Lipid Management u0026 the CLEAR Trial with Dr Michos (Radcliffe Cardiology)
View
|
 |
ACC 23 Late-Breaker Discussion: The REVIVED-BCIS2 Viability Study (Radcliffe Cardiology)
View
|
 |
ACC 23: Pulsed Field Ablation in Persistent Atrial Fibrillation Patients: The PULSED AF Trial (Radcliffe Cardiology)
View
|
 |
ππππ₯ π₯ππ πΌπππ₯π π£π€ SoMe Editor Mirvat Alasnag u0026 Associate Editor James Goldstein (CCI Journal)
View
|
 |
ACC 23: The STELLAR Phase III Trial: Sotatercept in Patients With Pulmonary Arterial Hypertension (Radcliffe Cardiology)
View
|